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Abstract 
Sheep are susceptible to the bovine spongiform encephalopathy (BSE) agent and in the UK they may have been 
exposed to BSE via contaminated meat and bone meal. An experimental sheep flock was established to determine 
whether ovine BSE could be naturally transmitted under conditions of intensive husbandry. The flock consisted of 
113 sheep of different breeds and susceptible PRNP genotypes orally dosed with BSE, 159 sheep subsequently born 
to them and 125 unchallenged sentinel controls. BSE was confirmed in 104 (92%) orally dosed sheep and natural 
transmission was recorded for 14 of 79 (18%) lambs born to BSE infected dams, with rates varying according to PRNP 
genotype. The likelihood of natural BSE transmission was linked to stage of incubation period of the dam: the attack 
rate for lambs born within 100 days of the death of BSE infected dams was significantly higher (9/22, 41%) than for 
the rest (5/57, 9%). Within the group of ewes lambing close to death, those rearing infected progeny (n = 8, for 9/12 
infected lambs) showed a significantly greater involvement of lymphoid tissues than those rearing non-infected 
offspring (n = 8, for 0/10 infected lambs). Horizontal transmission to the progeny of non-infected mothers was 
recorded only once (1/205, 0.5%). This low rate of lateral transmission was attributed, at least partly, to an almost 
complete absence of infected placentas. We conclude that, although BSE can be naturally transmitted through dam-
lamb close contact, the infection in this study flock would not have persisted due to low-efficiency maternal and 
lateral transmissions.
© 2015 Jeffrey et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The transmissible spongiform encephalopathies (TSEs) 
or prion diseases comprise a group of fatal neurological 
disorders affecting man, domestic ruminants, farmed and 
free-living cervid species, domestic and captive felids and, 
rarely, farmed mustellids. The infectious agent of TSEs is 
poorly characterised and diagnosis of prion diseases is 
generally achieved by detecting disease-associated forms 
of the prion protein (PrPd) using immunohistochemistry 
or immunoassay, or partially protease resistant forms of 
prion protein (PrPres) by molecular methods.
The bovine spongiform encephalopathy (BSE) epi-
demic of cattle in the UK and Europe was initiated 
and largely maintained by the inclusion of BSE con-
taminated meat and bone meal in concentrate feed-
stuffs [1, 2]. It is likely that at least some sheep and 
goats in the UK received concentrate feedstuffs that 
were at significant risk of containing the BSE agent. 
Many experimental studies have confirmed the sus-
ceptibility of sheep for the BSE agent and, moreover, 
there are suggestions that the ovine adapted BSE agent 
may be more virulent than the cattle agent [3]. How-
ever, no natural cases of BSE in sheep have yet been 
confirmed, though cases of caprine BSE have been 
identified in Europe [4, 5]. Any infection of sheep 
that may have occurred in the 1980s, when cattle BSE 
was first identified, would potentially have undergone 
many serial passages over generations with potential 
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for further adaptation and phenotypic changes in the 
nature of the disease.
Previous studies have reported that sheep are sus-
ceptible to BSE infection by several transmission 
routes including oral challenge [6–10], which might be 
expected to most closely mimic original exposure to the 
BSE agent. However, no studies have been carried out 
to study the potential for natural BSE transmission fol-
lowing initial exposure to contaminated feedstuffs. In 
contrast, scrapie is a naturally transmissible, contagious 
infection and a number of studies have shown several 
possible exposure sources deriving from infected dams. 
Although a large study of pre-implantation embryos 
found no evidence for trans-ovarial infectivity [11], 
other studies suggested that some foetuses may become 
infected in utero at late stages of gestation [12–14]. 
Infectivity [15] and PrPd [16, 17] is found in placentas 
of scrapie infected sheep allowing both for possible in 
utero infection via amniotic fluid ingestion by the foe-
tus and for post natal transmission following contamina-
tion of the environment. In separate experiments, milk 
obtained from scrapie infected sheep and goats was 
used to experimentally infect naïve new-born lambs of 
susceptible prion protein (PRNP) genotypes with high 
efficiency [18, 19]. Other studies suggest that horizon-
tal transmission to progeny of uninfected dams may be 
efficient under conditions of high infection pressure but 
less efficient when environmental contamination is less 
significant [20].
We have previously reported preliminary evidence of 
natural BSE transmission from dam to offspring [21]. 
This report describes the outcome of the complete, large-
scale study from which those preliminary observations 
were reported. The aim of the study was to determine the 
efficiency of natural transmission of BSE in sheep, includ-
ing those of maternal and horizontal transmission, the 
factors that could affect such efficiencies and the disease 
phenotype of naturally transmitted sheep BSE.
Materials and methods
PRNP genotyping
The PRNP genotypes of sheep to be orally dosed, to be 
introduced as sentinel controls or to be used for breeding 
purposes (see below) were determined prior to under-
taking the corresponding procedures (dosing, mixing or 
mating). Such genotyping was confined to codons 136, 
154 and 171 and sheep of three genotypes were selected: 
ARQ/ARQ, AHQ/AHQ and VRQ/VRQ (A, alanine 
or V, valine at codon 136; R, arginine or H, histidine at 
codon 154; Q, glutamine at codon 171). Since all ani-
mals included in this study were homozygotes at those 
three codons, a single allele denomination will be used 
throughout this report. During the course of this study, 
data emerged suggesting that New Zealand-derived Suf-
folk sheep with the ARQ allele might show an additional 
polymorphism at codon 112 (T, threonine instead of 
M, methionine), with influence on susceptibility to oral 
BSE [22]. In view of this, all ARQ sheep within the study 
(Romney and Suffolk, either orally dosed, their progeny 
or sentinel controls, see below) and a selection of Che-
viot sheep (20 VRQ and 25 AHQ) were subjected to full 
PRNP ORF genotyping by methods described previously 
[23].
BSE homogenates used for oral challenges
Three different cattle BSE homogenates were used 
for oral challenge: (1) BBP1, with a titre of 104.07 RIII 
mouse ic/ip LD50/g−1, (2) BBP6, not titrated in mice and 
(3) BBP8, a 50% dilution of an inoculum with a titre of 
RIII mouse 103.84 ic/ip LD50/g−1. In previous experi-
ments [10, González et  al., unpublished observations], 
the three cattle BSE inocula caused disease in ARQ 
sheep with similar attack rates (ARs) and survival times 
[STs: 589  ±  15  days (mean  ±  standard deviation, SD) 
for BBP1, 619  ±  24  days for BBP6 and 530  ±  14  days 
for BBP8] that did not clearly parallel the infectivity 
expected from mouse titres.
Experimental animals
To establish the flock, sheep of selected breeds and PRNP 
genotypes were obtained from a New Zealand-derived, 
classical scrapie-free flock (ARSU, APHA, UK) and orally 
dosed with the different cattle BSE inocula listed above 
(Figure 1). PRNP ORF genotyping done well after experi-
mental challenges were completed detected the M112T 
polymorphism in 48 ARQ Suffolk sheep (17 orally dosed 
and 31 progeny); since none of these sheep (Figure 1) or 
the 10 M112T sentinel controls showed evidence of BSE, 
those 58 sheep have not been included in this report. 
Additional polymorphisms were not detected in ARQ 
Romney sheep or in VRQ and AHQ Cheviot animals.
A total of 113 sheep were orally dosed. Six Suffolk 
sheep were given 1 g of inoculum at 6–10 days of age and 
the remaining 107 were dosed with 5  g of inoculum at 
different ages (Table 1): ARQ Suffolk sheep at either ~4–5 
(n = 13) or ~6–8.5 months (n = 4); ARQ Romney sheep 
at ~8 (n = 24) or ~11–12 months (n = 28); VRQ Cheviot 
sheep at  ~2 (n =  6) or  ~4  months (n =  4); AHQ Che-
viot sheep at ~2.5–4.5 (n = 19) or ~8–10 months (n = 9). 
Oral dosing of these sheep took place during the first 
8 years of the study: 2001, 28; 2002, 11; 2003, 5; 2004, 28; 
2006, 15; 2007, 5; 2008, 21.
Between one and 6  months following the initial oral 
challenges in 2001, an additional 58 non-dosed sheep 
(Figure 1) of the same breeds, genotypes and flock of ori-
gin were mixed with the dosed animals. Conventional 
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intensive husbandry practices were followed as far as 
possible whilst avoiding possible sources of iatrogenic 
transmission. All animals were kept in a single group 
housed in purpose built accommodation for the duration 
of the study (until 2013) without access to open pasture; 
they were offered forage ad libitum supplemented with an 
appropriate quantity of concentrate. Bedding was wood 
shavings for the life of the study and this was replenished 
as necessary to maintain dry bedding, although com-
plete removal of the bedding was required regularly. Both 
experimentally and naturally exposed ewes were bred 
from 18 months of age by natural mating using breed and 
genotype matched sires from the same scrapie-free flock 
and all sheep were given unrestricted access to lambing 
areas to maximise opportunity for spread of infection 
around lambing. Over successive years and lambing sea-
sons, 108 susceptible first generation (F1) lambs were 
born to BSE dosed dams (78 to dams that went on to 
develop BSE and 30 to dams that were dosed but did not 
develop BSE) and another 51 were the progeny of the F1 
generation (F2, 1 from a F1 dam that developed BSE and 
50 from non-infected F1 dams). Similarly, 57 sheep were 
the F1 and 10 the F2 of the 58 undosed sentinel controls. 
All these sheep were kept within the flock as explained 
below.
In summary, this report includes a total of 397 sheep 
that were (1) of susceptible PRNP genotype, (2) exposed 
to BSE through either experimental challenge, maternal 
contact or horizontal transmission and (3) resident in the 
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Figure 1 Overall layout of the study and its main results. The study comprised four groups (G1-G4) of sheep orally challenged with BSE and 
their progeny and one group (G5) of sentinel controls and their offspring. AR, attack rate, as percentage. Combined attack rates are: A) for orally 
dosed susceptible sheep (M112T Suffolk sheep excluded) including clinically affected animals and preclinical culls, 104/113 = 92.0%; B) for the sus-
ceptible F1 and F2 progeny of infected dams, 14/79 (17.7%); 5) for susceptible sheep exposed only to lateral transmission, 1/205 = 0.5%. For other 
details see Table 1.
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as infected after exposure. It does not include sheep of 
resistant genotypes or those that, although susceptible, 
died from intercurrent disease or were culled (for welfare 
reasons or to reduce stock density) at ages too young to 
make a BSE-negative diagnosis reliable. This age factor 
was breed and genotype dependent and worked out on 
the basis of previous experience on sheep BSE after oral 
infection [10, González et al., unpublished observations] 
and of the STs of sheep that succumbed to BSE during 
the present experiment (Table 1).
Sheep were monitored for clinical signs of neurological 
disease and humanely killed when BSE-compatible signs 
reached a predefined end-point, or culled because of old 
age, or at the termination of the study. Most of the flock 
Table 1 Details of the study design and results (attack rates and survival times).
n, number of sheep in each subgroup and group; AR, attack rate as percentage; ST, survival time in days as mean ± SD (range) for BSE infected sheep (actual days for 
the two F1 VRQ Cheviot sheep) and as mean (range) for survivors
a Only M112M ARQ Suffolk sheep included
b Age at exposure in days as range for the different subgroups and as mean ± SD for the breed/genotype/dose groups (rows in italics; in the case of orally dosed 
Cheviot VRQ, only those left to develop clinical disease are highlighted)
c Includes one BSE +ve animal culled at 371 dpi (not considered in ST values)
d These six sheep were culled at preclinical stage
e These two sheep were culled at the stated ages in the absence of clinical disease and found to be PrPd positive
Type of exposure Breed and genotypea Age at exposureb BSE infected Survivors
n AR ST n ST
Oral challenge Suffolk ARQ 1 g 9 ± 1 6c 100 575 ± 87 (525–729) 0
Suffolk ARQ 5 g 112–147 13 100 712 ± 119 (575–1034) 0
190–255 4 100 712 ± 106 (570–800) 0
145 ± 41 17 100 712 ± 113 0
Romney ARQ 5 g 230–253 21 87.5 830 ± 93 (665–1058) 3 2380 (2347–2397)
342–363 26 92.9 822 ± 149 (672–1365) 2 1580 (1562–1597)
304 ± 58 47 90.4 825 ± 126 5
Cheviot VRQ 5 g 54–58 2d 33.3 966–967 4d 954 (915–967)
126 ± 0 4 100 1772 ± 206 (1558–2026) 0
Cheviot AHQ 5 g 76–138 19 100 601 ± 54 (498–665) 0
229–294 9 100 597 ± 57 (524–686) 0
145 ± 80 28 100 600 ± 54 0
Total oral dosing 104 92.0 9
F1/infected dam Suffolk ARQ From birth 5 27.8 787 ± 101 (654–893) 13 1096 (535–2647)
Romney ARQ “ 7 16.7 870 ± 154 (673–1084) 35 2020 (693–2674)
Cheviot VRQ “ 2 11.8 1804, 1883e 15 1913 (1454–2247)
Cheviot AHQ “ 0 0 1 1276
F2/infected F1 Romney ARQ “ 0 0 1 1220
Total maternal 14 17.7 65
F1/not infected dam Suffolk ARQ From birth 0 0 10 999 (315–2662)
Romney ARQ “ 0 0 20 1116 (309–2621)
F2/not infected F1 Suffolk ARQ “ 0 0 9 997 (312–1580)
Romney ARQ “ 1 2.4 392e 40 1057 (309–2242)
Sentinels Suffolk ARQ From mixing 0 0 12 1614 (1277–1736)
Romney ARQ “ 0 0 30 2177 (1058–2959)
Cheviot VRQ “ 0 0 9 1526 (1203–1653)
Cheviot AHQ “ 0 0 7 1491 (695–1764)
F1–F2/sentinels Suffolk ARQ From birth 0 0 19 1034 (293–2243)
Romney ARQ “ 0 0 42 1559 (344–2621)
Cheviot VRQ “ 0 0 4 1018 (728–1840)
Cheviot AHQ “ 0 0 2 403 (298–507)
Total horizontal 1 0.5 204
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was depopulated in 2010, by which time all orally dosed 
sheep had either succumbed to BSE, had been culled due 
to old age, or killed with evidence of preclinical infection. 
Similarly, all sentinel controls (dams, F1 and F2) were 
culled by the same time in the absence of clinical disease. 
By 2010, most of the F1 and F2 progenies of BSE dosed 
sheep had also been killed for the above reasons or with 
clinical BSE and only some sheep born to BSE confirmed 
dams remained in the flock until 2013. Details on the STs 
of the different groups are given in Table 1.
In addition to clinical examination and to further assist 
in monitoring BSE infection within the flock, some sheep 
were subjected to immunohistochemical (IHC) examina-
tion of lymphoid tissue biopsies, either from palatine ton-
sil [16] or recto-anal mucosal associated lymphoid tissue 
(RAMALT) [24].
All procedures were approved under the Animal (Sci-
entific Procedures) Act 1986 and by the Veterinary Labo-
ratories Agency (currently APHA) ethics committee and 
carried out under Home Office Project Licences numbers 
PPL70/4495, PPL70/5781 and PPL70/6795.
Post‑mortem and laboratory testing
All sheep that died or were culled were subject to nec-
ropsy and a range of tissue samples were taken including 
brain and a selection of lymphoreticular system (LRS) 
tissues. Additionally, some placentas were recovered 
after lambing and available for laboratory examinations. 
From each sheep in the flock a minimum set of samples, 
including brain at the obex and cerebellum, retropharyn-
geal lymph node and  distal ileum was examined; sheep 
that were positive for PrPd in any of those tissues were 
examined more widely, including an additional set of 
five standard brain areas, palatine tonsil, mesenteric and 
prescapular lymph nodes and spleen. All tissue samples 
were fixed in formaldehyde and processed for standard 
histology and immunohistochemistry (IHC).
The presence of PrPd was confirmed in brain and other 
tissues by IHC methods previously described [25]. In 
addition, brain and LRS tissues from all confirmed BSE 
cases were examined by discriminatory IHC methods 
using P4 monoclonal antibody (R-Biopharm, Darm-
stadt, Germany) recognising the ovine PrP amino acid 
sequence 93–99 (WGQGGSH [26]) and R145 monoclo-
nal antibody (APHA, Weybridge, UK), which recognises 
the amino acid sequence RESQA at positions 222–226 
of ovine PrP [5]. Brains and LRS tissues were scored for 
magnitude and types of PrPd accumulation using meth-
ods and protocols previously reported [25, 27].
Statistical analyses
Attack rates between the different experimental groups 
were compared by means of Fisher’s exact tests, while 
differences between mean STs of the different groups 
and average PrPd values in brain and LRS tissues were 
assessed using Student’s two sample unpaired t test. In 
both analyses, P  <  0.05 values were considered statisti-
cally significant.
Results
Sheep orally challenged with cattle BSE brain 
homogenates
Attack rates were 100% for M112M ARQ Suffolk sheep 
(23/23), for AHQ Cheviot sheep (28/28) and for VRQ 
Cheviot sheep left to develop clinical disease (4/4). These 
figures were higher, though not significantly different 
(P > 0.1 in all comparisons), than the 90.4% AR (47/52) 
observed for ARQ Romney sheep. ARs were identical 
regardless of the inoculum (BBP1, BBP6 or BBP8) and the 
dose (1 or 5 g for Suffolk sheep) used. Six VRQ Cheviot 
sheep were culled at preclinical stage (at approximately 
half of the ST of those left to develop clinical disease; 
Table 1) and BSE could only be confirmed in two of them 
(33%; Figure 1; Table 1).
Survival times of orally dosed sheep are shown in 
Table  1 and Figure  2. Of the six M112M ARQ Suffolk 
sheep dosed with 1  g of cattle BSE, one was culled at 
371 days post-infection (dpi) and showed PrPd accumu-
lation in brain and LRS tissues at necropsy. The other 
five succumbed to clinical BSE with STs of 575 ± 87 dpi 
(mean ± standard deviation). Amongst sheep dosed with 
5  g of inoculum, STs were shortest for AHQ Cheviot 
sheep (600 ± 54 dpi) and most protracted for VRQ Che-
viot sheep (1772 ± 206 dpi), with intermediate values for 
M112M ARQ Suffolk (712 ± 113 dpi) and ARQ Romney 
sheep (825 ± 126 dpi). Differences in ST were significant 
between each of these four groups (Figure  2), including 
between Suffolk and Romney sheep of the same ARQ 
genotype. As with the ARs, no differences in ST were 
observed that could be attributed to the inocula. Moreo-
ver, within each of the three groups of ARQ Suffolk and 
Romney and AHQ Cheviot sheep dosed with 5 g of cat-
tle BSE, no differences in ST were observed between 
subgroups that differed in their age at challenge (statisti-
cal analyses not shown but can be inferred from data in 
Table 1).
Sheep of susceptible PRNP genotypes exposed to natural 
horizontal transmission only
These animals included the sentinel controls (n = 58) and 
their progeny (n =  67), the F1 (n =  30) of orally dosed 
ewes that did not develop BSE and the F2 (n  =  49) of 
non-infected F1. Of a total of 205 sheep, all of which were 
of susceptible PRNP genotype and either in contact with 
infected sheep or exposed to potentially contaminated 
environment for periods running into years (Table  1), 
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only one Romney sheep, culled at 392  days of age, was 
confirmed PrPd positive in brain. This sheep was the off-
spring of a non-infected F1 born to an orally dosed Rom-
ney sheep that developed BSE (Figure 1).
Sheep of susceptible PRNP genotypes exposed to natural 
maternal and horizontal transmission
These animals included the F1 (n =  78) of orally dosed 
sheep that developed BSE and the F2 (n = 1) of infected 
F1. Fourteen of these 79 sheep (17.7%) showed evidence 
of BSE infection when examined at post-mortem. The 
following is an analysis of these transmissions within the 
different breed/genotype groups.
Of the 23 M112M ARQ Suffolk sheep that developed 
BSE after oral infection, 11 did not lamb, in most cases 
because they succumbed to BSE prior to first lambing 
(only one was a male). Of the remaining 12, seven gave 
birth to 11 F1 progeny that did not develop BSE and the 
other five had seven F1, five of which became infected 
(Table  2). Similarly, only 33 (32 orally dosed and one 
F1) of the 54 BSE-infected ARQ Romney ewes (47 orally 
dosed and seven F1) lambed and of those, only six dams 
raised seven infected progeny out of eight born to them. 
Overall, a total of 45 BSE-infected ARQ sheep had sus-
ceptible progeny (n  =  61) but only 11 of them (24.4%) 
reared BSE infected offspring. However, 12 of 15 sheep 
(80%) born to these 11 dams succumbed to BSE. Of the 6 
BSE-infected VRQ Cheviot sheep, two did not lamb, two 
had BSE-negative progeny (n  =  10) and the other two 
produced seven F1 lambs, two of which were shown to 
be BSE infected at post-mortem examination. The ARs 
in the progeny of infected dams was not statistically dif-
ferent between ARQ Suffolk (5/18, 27.8%), ARQ Romney 
(7/43, 16.3%) and VRQ Cheviot (2/17, 11.8%) sheep. Of 
the 28 BSE-infected AHQ Cheviot sheep, eleven were 
males and only one of the 17 ewes lambed; the only 
lamb born to that ewe did not show evidence of BSE by 
1276 days of age.
Overall, 50 BSE infected ewes lambed in a 7 year period 
(2003–2009). Eighty-eight lambs were born to those 
dams, of which nine did not survive for long enough to 
be considered (see “Materials an methods”), 14 went on 
to develop BSE and 65 did not show evidence of infec-
tion. The number of lambs born to BSE infected ewes in 
the different years was: 2003, 13; 2004, 5; 2005, 23; 2006, 
19; 2007, 14; 2008, 12; 2009, 2.
Statistical analysis of the efficiency of the different 
transmissions
The AR for PRNP susceptible sheep orally dosed with 
cattle BSE (104/113, 92.0%) was substantially higher than 
that in the offspring (F1 + F2) of infected sheep, whether 
all dams are considered (14/79, 17.7%, odds ratio [OR] 
53.6, 95% confidence interval [CI] 21.9-131.1, P < 0.001) 
or only those raising BSE infected progeny are taken 
into account (14/22, 63.3%, OR 6.6, 95% CI 2.2–19.9, 
P < 0.01).
Despite differences in ARs between experimental oral 
challenge and natural maternal transmission, the mean 
STs of the BSE-affected ARQ Suffolk F1 (787 ± 101 days) 
and ARQ Romney F1 sheep (870 ±  154  days) were not 
significantly longer than those observed in the parental 








Figure 2 Survival times in relation to ages at infection. Survival time (X axis in days, mean ± SD) of orally dosed sheep (solid symbols; squares, 
5 g dose and circle, 1 g dose) and naturally exposed progeny (open symbols) in relation to their age at exposure (Y axis in days, mean ± SD; for 
naturally exposed progeny, the age has been arbitrarily defined as around birth). Black, ARQ Suffolk sheep; blue, ARQ Romney sheep, green, VRQ 
Cheviot sheep; red, AHQ Cheviot sheep. Note that (1) the survival times of orally dosed AHQ Cheviot sheep are similar (low standard deviation) 
despite noticeable differences in age at exposure (see Table 1 for details) and (2) the survival times of orally dosed sheep are similar to those of 
naturally exposed progeny of the same breed and genotype.
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stock (Table  1; Figure  2). A similar comparison could 
not be made for VRQ Cheviot F1, since only one of them 
died of clinical BSE at 1804 days (the other infected off-
spring was detected when culled at 1883  days in the 
absence of clinical signs). However, the STs of naturally 
infected ARQ Suffolk progeny (787 ± 101 days) were sig-
nificantly longer (P  <  0.01) than those of the ARQ Suf-
folk lambs dosed with 1 g of cattle BSE shortly after birth 
(575 ± 87 days; Table 1; Figure 2).
The risk of developing BSE was more than 35 times 
higher (relative risk (RR) 36.3, 95% CI 4.8–271.8, 
P  <  0.001) for sheep born to infected ewes (14/79, 
17.7%) compared to animals born to uninfected ewes 
(1/205, 0.5%, including the 58 sheep of the parental 
stock; Table 1).
Factors affecting the likelihood of maternal transmission 
of BSE
Within the progeny of infected ewes, the likelihood 
of infection appeared to be influenced by the degree of 
proximity between lambing and the death of the dam 
due to BSE (Figure 3). No BSE positive lambs arose from 
18 births occurring in the first 50% of ST of orally dosed 
dams, seven infected lambs were bred from 43 (16.3%) 
born in the 51–90% range of dam ST and 38.9% (7/18) of 
lambs born in the last 10% of dam’s ST became infected. 
In absolute terms, the ARs in the F1 offspring were high-
est amongst lambs born within less than 100 days from 
the death of the ewe (9/22, 40.9%), intermediate in those 
born between 100 and 300 days of the dam’s death (3/15, 
20%) and lowest for those born earlier than 300  days 
before the dam’s death (2/42, 4.8%).
Fisher’s test analysis of those figures indicated a signifi-
cantly higher probability of progeny becoming infected 
for dams lambing in the last 10% of their survival period 
(RR 3.4, 95% CI 1.4–8.4, P < 0.05) compared with the rest 
(7/61, 11.5%). Similarly, the risk of developing BSE was 
significantly higher for lambs born within 100 days of the 
dam’s death (RR 4.7, 95% CI 1.8–12.4, P < 0.01) than for 
the rest (5/57, 8.8%).
Two further analyses were carried out to try to explain 
why some of the offspring born from dams that were 
close to their death went on to develop BSE whereas 
some other did not. These analyses were focused on the 
16 dams that lambed within 100 days of their death due 
to BSE and produced 9 infected and 13 non infected off-
spring (Table  3). In the first analysis it was found that 
the time that elapsed between lambing and death of the 
dam was not significantly different between the eight 
that produced 9/12 infected offspring (55  ±  28.4  days) 
and the other eight raising 0/10 infected progeny 
(60 ± 26.2 days). The second analysis was driven by the 
notion that the spread and severity of PrPd accumulation 
in LRS tissues can be taken as surrogate for the degree 
Table 2 Details of lambing and attack rates in progeny.
a Includes the 47 sheep developing BSE after oral infection and the seven BSE-infected F1, one of which had a negative descendant (Figure 1). Only 50 BSE infected 
sheep had progeny that stayed in the flock for sufficient time; the other 61 were either males, died to BSE before lambing, or lambed sheep that died at too young an 
age to be considered (see text). Of the 50 ewes that lambed only 13 (A) had progeny of which some sheep (14/22) went on to develop BSE; the remaining 37 ewes did 
not produce any positive offspring amongst 57 sheep born to them
Genotype and 
breed
BSE +ve sheep  
that lambed
BSE +ve dams with  
+ve offspring (A)
Attack rates in offspring
Born to (A) Total born
ARQ Suffolk 12/23 (52.2%) 5/12 (41.7%) 5/7 (71.4%) 5/18 (27.8%)
ARQ Romneya 33/54 (61.1%) 6/33 (18.2%) 7/8 (87.5%) 7/43 (16.3%)
VRQ Cheviot 4/6 (33%) 2/4 (50.0%) 2/7 (28.6%) 2/17 (11.8%)
AHQ Cheviot 1/28 (3.6%) 0/1 (0.0%) 0/1 (0%)
Total 50/111 (45.0%) 13/50 (26.0%) 14/22 (63.6%) 14/79 (17.7%)











% of dam’s survival time at lambing 
n 
Figure 3 Outcome of BSE infection in the offspring as a factor 
the proximity of lambing time to death of the dam. Black and 
white bars represent the number of lambs (Y1 axis) that did or did 
not develop BSE, respectively. Diamonds represent the same data as 
percentage (Y2 axis). Note that BSE infected progeny were born only 
to dams that lambed at 50% or later of their survival time and that 
the proportion of offspring that went on to develop BSE (efficient 
maternal transmission) increased with the proximity between parturi-
tion and death of the dam due to BSE.
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of systemic prion infection. In this analysis it was found 
that, at post-mortem examination of the dams, the sum 
of PrPd scores in six LRS tissues was significantly higher 
(P < 0.05) in the first group of dams (10.8 ± 1.8) than in 
the second (7.3 ± 3.5).
Detection of PrPd in placentas and biopsies
Placentas were available from 40 orally dosed ewes 
that went on to develop clinical disease and multiple 
fixed tissue samples were examined by IHC for PrPd 
detection. From a total of 66 such placentas, PrPd was 
not detected in any of the 45 placentas collected from 
31 infected dams whose progeny did not develop BSE, 
despite the fact that many of those placentas were 
obtained after the dam had shown peripheral PrPd accu-
mulation in tonsil and/or RAMALT biopsies (results not 
shown). The other 21 placentas were obtained from 10 
dams whose progeny (all or some) went on to develop 
BSE (Figure 4). Only one placenta showed PrPd accumu-
lation by IHC, despite the fact that 11/21 corresponded 
to lambs that developed BSE and were obtained either 
after (6/11) or close (2/11) to a positive tonsil/RAMALT 
biopsy result in the dam (Figure  4). The only PrPd-
positive placenta was from a VRQ Cheviot lamb still-
born from a dam (C3 in Figure 4) that in two previous 
deliveries produced an animal that developed BSE and 
a stillbirth, both with negative placentas. All three biop-
sies examined from this dam were negative; the latest 
was taken 1 year after the birth of the lamb that became 
BSE infected and 1 year before the delivery of the posi-
tive placenta.
The birth of eight of the 14 lambs that developed BSE 
was preceded by a positive biopsy result in the dam (S1, 
S2, S3, R2, R5, R7 and C1 in Figure 4). In three cases (S5, 
S6 and R10), the positive biopsy was obtained after the 
birth of the BSE-positive lambs but there were no biop-
sies examined beforehand. One BSE positive lamb was 
born after a negative biopsy in the dam taken 125  days 
before lambing (R11) and two BSE positive lambs (R12 
and C3) were born before a biopsy from the dam was 
examined with negative result. Biopsies were also taken 
from 34 BSE-infected dams that produced fully BSE-neg-
ative offspring, with 17 of those dams giving consistently 
negative biopsy results on a total of 36 biopsy speci-
mens. The other 17 dams yielded positive biopsy result 
after examining a total of 28 biopsies (biopsies were only 
repeated until a positive result was obtained and ceased 
after that). Only two of those 17 dams gave a positive 
biopsy result before (around 4 months) lambing, another 
two did so within a month of lambing and the other 13 
Table 3 Details of dams that died of BSE within 100 days of final lambing.
SD, standard deviation; ID, sheep identification; S, ARQ suffolk; R, ARQ romney; C, VRQ Cheviot; P, BSE positive; N, BSE negative; Dpi AL, days post-oral challenge at 
lambing; ST, survival time; Diff., days difference between ST and Dpi AL; RphLN, medial retropharyngeal lymph node; PTon, palatine tonsil; MsnLN, mesenteric LN; 
PrsLN, prescapular LN; DIle, distal ileum (Peyer’s patches); LRS, sum of lymphoreticular system tissue scores
ID Offspring Time intervals Lymphoreticular system involvement
Dpi AL ST Diff. RphLN PTon Spleen MsnLN PrsLN DIle LRS
S1 P 621 664 43 2 2.5 2 2 1.5 2.5 12.5
S2 P and N 623 677 54 3 2 1.5 1 0.5 2.5 10.5
S3 P and N 623 664 41 2.5 2 2 1.5 2 2 12.0
S5 P 496 570 74 2 2 2 2 2 2 12.0
R2 P 709 800 91 0.5 1.5 2 0.5 0.5 2.5 7.5
R5 P 703 706 3 2 3 2 0.5 0.5 2 10.0
R7 P and P 862 911 49 2.5 3 2 1 1.5 2.5 12.5
C1 P and N 1941 2026 85 3 1.5 1 0 1.5 2 9.0
Total 9/12 Mean ± SD 55 ± 28.4 Mean ± SD 10.8 ± 1.8
S4 N and N 983 1034 51 0.2 0.5 1.5 0 0.2 0.2 2.6
R1 N 706 786 80 2 2.5 2 0.5 0.5 2 9.5
R3 N 704 755 51 2 2.5 2 0 0.5 2.5 9.5
R4 N 705 766 61 0.5 3 2 1 2 3 11.5
R6 N 704 756 52 2 2 2.5 0.5 1 1.5 9.0
R8 N 861 871 10 1.5 1.5 1 1 1 1.5 7.5
R9 N 658 730 72 0.5 1 3 0.5 0.2 2 7.2
C2 N and N 1564 1663 99 0 0 1.5 0 0 0 1.5
Total 0/10 Mean ± SD 60 ± 26.2 Mean ± SD 7.4 ± 3.5
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were biopsy positive well after (around 7–12 months) the 
lamb was born.
Accumulation of PrPd in BSE‑infected dams and progeny
Terminal BSE cases showed extensive vacuolation of 
brainstem and PrPd accumulation throughout the neu-
raxis and cerebellum with generally lower PrPd levels in 
the cerebral cortex. However, the total magnitude of PrPd 
accumulation in the brain differed markedly between 
individual sheep within a same breed/genotype/route 
of exposure group, making differences between groups 
not significant (Figure  5A). Moreover, the total magni-
tude of PrPd accumulation in the brain did not appear 
to correlate with the survival time of the animals. Thus, 
the highest PrPd levels were found in orally dosed VRQ 
Cheviot (13.5  ±  3.4), AHQ Cheviot (12.7  ±  3.0) and 
ARQ Romney (12.8 ± 2.3) sheep, which showed signifi-
cant differences in survival times (see previous text and 
Figure  5A). Similarly, the magnitude of PrPd deposition 
in the brain was similar for sheep orally dosed and their 
progeny, as exemplified by the PrPd scores in ARQ Suf-
folk (10.7 ± 2.8 and 11.2 ± 3.4, respectively) and Romney 
(12.8 ± 2.3 and 11.2 ± 3.5, respectively) sheep.
In most clinical cases of BSE, significant PrPd levels 
were also found in a range of LRS tissues. This is con-
sistent with a generalised distribution of infectivity 
1804
days












































Figure 4 Diagrammatic representation of the progression of BSE infection in 13 dams that produced the 14 infected offspring. (S, 
ARQ Suffolk sheep, R, ARQ Romney sheep, C, VRQ Cheviot sheep). *These dam ID numbers coincide with those in Table 3. Green diamonds, age 
at inoculation. Circles, biopsy result (white, last negative; red, first positive). L within white square, age at lambing. Stars next to lambing, placenta 
result (white, negative; red, positive). X, stillbirth. Black squares, dam’s age at death of BSE (note that some squares appear partially hidden because 
of proximity between lambing and death). Blue and white squares, age at death of infected and non-infected progeny, respectively (indicated by 
digits, discontinuous lines are not representative).
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throughout the carcase by the time animals reached clini-
cal end point. However, as in the brain, the abundance 
of PrPd in LRS tissues also varied markedly between 
individuals and between groups (Figure  5B). It was also 
noted that the amount of PrPd in the brain was unre-
lated to that in the LRS, so that the lowest LRS involve-
ment was detected in orally dosed VRQ Cheviot sheep 
with the highest brain PrPd (4.6  ±  2.8 and 13.5  ±  3.4, 
respectively), while naturally infected Suffolk sheep, 
with an intermediate PrPd brain score, showed the high-
est magnitude of LRS PrPd accumulation (11.2 ± 3.4 and 
15.0 ± 1.1, respectively).
When performing discriminatory IHC with N- and 
C-terminal antibodies it was observed that the char-
acteristic BSE truncation pattern (lack of reactivity of 
intracellular PrPd with P4 antibody) was common to all 
sheep regardless of their breed, genotype and type of 
exposure. Equally, the BSE-characteristic PrPd profile in 
brain (high levels of intraneuronal, intraglial, stellate and 
linear PrPd types) was common to all sheep regardless of 
differing experimental factors.
Discussion
This study provides compelling evidence that sheep BSE 
is naturally transmissible and contagious. This is in con-
trast to the report by Foster et al. [28], who did not find 
evidence of maternal transmission in nine susceptible 
offspring from four BSE-infected dams. In the present 
study, 14 lambs born to BSE infected dams and another 
born to a non-infected dam either developed clinical BSE 





















Figure 5 Accumulation of PrPd in CNS and LRS tissues in relation to survival times. Magnitude of PrPd accumulation in the brain (A; Y axis 
as mean ± SD of individual sheep scores for total PrPd (=sum of scores in seven standard brain areas)) and in LRS tissues (B; Y axis as mean ± SD 
of individual sheep scores for total PrPd (=sum of scores in six different lymphoid tissues)) of sheep clinically affected with BSE after oral (solid 
symbols) or natural (open symbols) transmission in relation to their survival times (X axis in days, mean ± SD). Black, ARQ Suffolk sheep (circle, 1 g 
dose; square, 5 g dose); blue, ARQ Romney sheep; green, VRQ Cheviot sheep; red, AHQ Cheviot sheep. For number of animals in each group refer 
to Table 1. Note that (1) there is significant individual variation in PrPd scores in both brain and LRS tissues, (2) brain PrPd scores are relatively similar 
between groups regardless of differences in survival time and (3) LRS scores are low for VRQ Cheviot sheep despite their long survival time and high 
brain PrPd.
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or were positive for PrPd when culled. Moreover, since 
the relative risk of infection was much higher (around 35 
times) for the progeny of infected dams (~18%) than for 
the offspring of non-infected ewes (~0.5%), we conclude 
that, within the context of the experimental design of this 
study, natural BSE transmission occurs mostly from dam 
to offspring, that is, through a maternal or vertical route. 
The importance of maternal transmission as a means of 
maintaining endemic infection has previously been well 
documented for classical scrapie [20, 29–31], but there 
is neither epidemiological nor experimental evidence for 
maternal transmission of cattle BSE [32, 33].
It has recently been suggested that sheep foetuses 
may be infected with classical scrapie in utero [12–14]. 
In the present experiment, the lack of PrPd detection in 
the placentas of the offspring that went on to develop 
BSE (Figure 4) and the fact that in some twin births only 
one lamb became infected (Table 3), do not suggest that 
maternal transmission occurred in utero. However, the 
relatively small SDs in the ST of the infected Suffolk and 
Romney F1 progeny, which were comparable to that in 
the corresponding orally dosed parental stock (Table  1; 
Figure 2), suggest that all those offspring became infected 
with similar infectious doses and at a similar time. Since 
STs of the offspring did not differ from that of the parental 
stock (Table 1; Figure 2), it is likely that infection occurred 
shortly after birth, and certainly before 3  months of age 
when lambs were separated from their dams. The pre-
cise maternal source of infectious agent for the progeny 
cannot be determined in this study. By comparison with 
classical scrapie, blood and other birth fluids, saliva [34] 
and milk [18, 19] are all potential sources of BSE agent. 
Infectivity in the last two secretions most probably 
reflects presence of the infectious agent in blood (prio-
naemia) rather than true replication of the agent in the 
salivary and mammary glands. This possibility is further 
suggested by the higher levels of PrPd found in the LRS of 
dams with infected progeny compared to those with unin-
fected offspring (Table 3) and by the increased probability 
of infection in lambs born to ewes that lambed close to 
their death from BSE (Figure 3), that is, in advanced stages 
of the incubation period. This late preclinical disease stage 
is when dissemination of the infectious agent throughout 
the LRS is at its peak, as shown by studies on sheep BSE 
[7, 8, 10] and on sheep scrapie [35–38] and when prio-
naemia reaches highest levels, as demonstrated by blood 
transfusion experiments [39].
Lambs that were naturally infected from their dams, 
survived significantly longer than lambs receiving 1  g 
oral dose at 6–10  days of age (Figure  2). On one hand, 
this could be due to natural infection occurring at an 
older age than 10  days but still before weaning. On the 
other hand, it could suggest that the infection passed 
from dams to lambs was less that the equivalent titre 
represented by a 1 g oral infectious dose. This relatively 
low maternal infectious dose would also be in agreement 
with the significantly lower AR observed in the offspring 
compared to the orally dosed dams and with the fact that 
in some twin parturitions one lamb became infected and 
the other did not (Figure  4). However, a low infectious 
maternal dose may be difficult to reconcile with the fact 
that the survival times of the naturally infected prog-
eny were actually no longer than those observed in their 
dams, which were given a 5 g dose. The explanation may 
lie in the age difference at infection between naturally 
infected offspring (pre-weaning) and their dams (average 
5 months for Suffolk and 10 months for Romney sheep), 
which would make young lambs significantly more sus-
ceptible to BSE than weaned lambs and young adults, as 
has already been shown in a different study [9].
The results of this study thus show that BSE infected 
dams can transmit infection to their progeny. However, 
the excretion of the infectious agent is either discon-
tinuous and/or its level variable. Thus, only some lambs 
–particularly those born at late preclinical stage of the 
dams—would receive an efficient dose and develop dis-
ease with relatively short incubation periods, while oth-
ers would remain uninfected (at least as shown by PrPd 
detection within the context of the study). Husbandry 
factors may also be important to explain the lack of trans-
mission to some of the uninfected offspring. Dams incu-
bating BSE were often poor mothers and, as is common 
practice in commercial farming, poorly mothered new-
born lambs were often reared by other ewes, including 
sentinel controls and ewes at early BSE incubation stages. 
Efforts to trace back information about each individual 
lamb were unsuccessful because of the large scale of the 
study and its duration.
One sheep that was the progeny of a non-infected 
Romney F1 ewe was found to be BSE-infected. Assum-
ing that there were no confounding management fac-
tors (e.g. that this lamb suckled from an infected ewe), 
this finding is indicative of the occurrence of horizontal 
or lateral BSE transmission. However, despite the flock 
being kept indoors for the duration of the study, the level 
of true horizontal transmission found in this study was 
very low (~0.5%) and certainly much lower than that 
observed for classical scrapie, where a high proportion 
of sheep of susceptible genotypes born to non-infected 
dams can become infected in a heavily contaminated 
environment [20]. A possible explanation for the differ-
ence between scrapie and sheep BSE in this respect lies 
in placental infectivity. In classical scrapie, a high propor-
tion of placentas from infected ewes harbouring foetuses 
of susceptible genotype are infectious and/or contain 
detectable PrPd/PrPres [16, 17, 40–43] and such infected 
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placentas are regarded as one of the most important, if 
not the main, sources of environmental contamination 
and horizontal transmission [20, 44]. In contrast, in this 
study, where BSE infected dams had foetuses and pla-
centas of the same susceptible genotypes, only one pla-
centa was found to be PrPd positive. This was despite 
many placentas corresponding to lambs that went on 
to develop BSE or others being collected once the dam 
had shown peripheral prion replication as demonstrated 
by PrPd positive biopsy. Arrival of infectivity in the pla-
centa is most likely through the haematogenous route 
and, since a high number of BSE infected dams showed 
LRS involvement around gestation, their placentas are 
likely to have been exposed to the infectious agent. This 
would therefore suggest that there is a difference between 
the scrapie and BSE agents’ ability to replicate in the pla-
centa, although without proper comparative kinetics data 
between scrapie and BSE infected sheep such a possibil-
ity cannot be ascertained. Nevertheless, regardless of the 
pathogenetic mechanism, the almost complete lack of 
placental PrPd detected in this study is probably a sig-
nificant factor in the low rate of horizontal transmission 
observed.
In addition to placentas, environmental contamina-
tion at lambing time may be due to birth excreta such as 
blood and amniotic fluid from infected dams, which were 
not tested in the course of this study. Even if those fluids 
were infectious, the level of environmental contamina-
tion would have been low, since only a few (50 in 7 years) 
BSE infected dams lambed each year and even fewer 
(between 0 and 4 per year for a total of 13 in 7  years) 
lambed offspring that went on to develop BSE. In other 
words, pressure of infection at lambing time, which has 
been recognised as an important factor for sheep scrapie 
[20], would have been low in the experimental set up of 
this study. This would have contributed to low environ-
mental contamination and negligible horizontal trans-
mission, as observed.
In order to achieve endemic BSE within a flock, hori-
zontal and/or maternal transmission of infection must 
be efficient. This was not the case in the present study. 
Only a single lamb became infected by putative hori-
zontal transmission. Of 99 BSE orally infected ewes, 
49 succumbed to BSE before lambing or had progeny 
that died at young age (without having lambed) and 50 
lambed viable offspring. Thirty-seven of these dams, 
most of which lambed only once before succumbing 
to BSE, had an uninfected progeny. Of the remaining 
13, one (C1 in Figure  4) had multiple parturitions with 
only one of six lambs becoming infected, one (R5) had 
two parturitions with only one of two lambs becoming 
infected and the remaining 11 ewes had only one lamb-
ing, with 12/14 lambs developing BSE. Only one of these 
ewes (R7) produced a set of twins both of which devel-
oped infection; the rest only reared single infected prog-
eny. Moreover, of the 14 F1 progeny that developed BSE, 
only 6 sheep (2 each of ARQ Suffolk, ARQ Romney and 
VRQ Cheviot sheep) were females. In other words, out 
of almost a hundred infected ewes of the parental stock 
only slightly more than 6% of the sheep of the F1 genera-
tion were in a situation of transmitting infection to the 
next generation and the only one that lambed did not 
transmit. Thus, although the results of this study clearly 
indicate that natural transmission of BSE can occur, they 
do not provide strong evidence for multigenerational 
maintenance of infection. This conclusion would agree 
with the absence of any BSE-like case in a retrospective 
study on more than 2000 natural ovine TSEs diagnosed 
between 1998 and 2004 [45]. However, a perhaps impor-
tant caveat of the present experiment is the rapidity with 
which orally dosed dams succumbed to BSE. In a differ-
ent scenario, perhaps with a lower oral dose, infected 
dams could have had the opportunity to lamb in several 
successive seasons and this could have led to a higher 
opportunity to raise infected progeny and/or to increase 
environmental contamination at lambing time. There-
fore, the possibility that ovine BSE may show greater 
trans-generational spread of infectivity under conditions 
of high infectivity pressure, which was not the case in this 
experiment, cannot be ruled out.
This study has also provided some additional informa-
tion regarding the pathogenesis of sheep BSE after oral 
infection. Firstly, the resistance of M112T ARQ Suffolk 
sheep to oral BSE, which confirms previous reports [10, 
22]; in this respect BSE differs from oral scrapie, for which 
the threonine polymorphism at codon 112 confers only 
partial resistance, both in terms of AR and ST [23]. Sec-
ondly, the poor correlation between clinical disease, mag-
nitude of PrPd in the brain and survival time (Figure 5A); 
this is in agreement with previous reports on experi-
ments done by the oral [10] and the intracerebral [25] 
routes. Thirdly, that non-PrP genetics may be involved in 
the relative proportion of PrPd in the brain and LRS tis-
sues. Thus, when pooling data from parental stock and F1 
together, ARQ Romney sheep showed higher brain PrPd 
for lower LRS PrPd compared with Suffolk sheep of the 
same genotype, which showed the reverse pattern (results 
not shown but can be inferred from Figures  5A and B); 
this is in agreement with the findings of other sheep BSE 
experiments [10, González et  al., unpublished observa-
tions). Fourthly, that VRQ sheep appear to be, in terms of 
survival time, less susceptible to cattle BSE than to some 
forms of classical sheep scrapie, which might be related to 
low replication of the agent in the LRS (Figure 5B) of BSE- 
compared to scrapie-infected sheep (for review see [46]); 
however, long incubation periods in VRQ sheep have 
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also been reported for sheep scrapie, when the infectious 
source is of a heterologous ARQ genotype [23]. Finally, 
that both in terms of truncation site of intracellular PrPd 
and of brain PrPd profile, BSE in the naturally infected 
animals is indistinguishable from that in the donor ewes; 
this finding is in agreement with those obtained on serial 
experimental passage of BSE in sheep [47].
In conclusion, the results of the present study show 
that transmission of BSE from dam to offspring may 
occur. However, the low efficiency of maternal transmis-
sion and the almost complete lack of horizontal trans-
mission do not suggest that BSE infectivity is likely to 
be self-sustaining within sheep flocks, at least within the 
context of the experimental design reported here and the 
caveats already expressed.
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